CAMCEVI PROLONGED-RELEASE SUSPENSION FOR INJECTION 42 MG PER SYRINGE
Product details
Registration number: SIN17580P
Classification: Prescription Only
Active ingredients: Leuprorelin mesilate eqv to leuprorelin
Strength: 42 mg/ syringe
Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE
Route: SUBCUTANEOUS
Registrant: GENSCI SINGAPORE PTE. LTD.
ATC code: L02AE02
HSA approval date: 8 July 2026
Manufacturer(s):
- Fareva Pau
- Sterigenics Belgium (Fleurus) (Contract Sterilization)
Manufacturing country/countries: FRANCE; BELGIUM
What are the HSA registration number and classification for CAMCEVI PROLONGED-RELEASE SUSPENSION FOR INJECTION 42 MG PER SYRINGE?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN17580P
Classification: Prescription Only
What active ingredients and strength are recorded for CAMCEVI PROLONGED-RELEASE SUSPENSION FOR INJECTION 42 MG PER SYRINGE?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Leuprorelin mesilate eqv to leuprorelin
Strength: 42 mg/ syringe
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for CAMCEVI PROLONGED-RELEASE SUSPENSION FOR INJECTION 42 MG PER SYRINGE?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, SUSPENSION, EXTENDED RELEASE
Route: SUBCUTANEOUS
Who is the recorded registrant for CAMCEVI PROLONGED-RELEASE SUSPENSION FOR INJECTION 42 MG PER SYRINGE?
According to the HSA dataset updated 7 August 2026:
Registrant: GENSCI SINGAPORE PTE. LTD.
Which manufacturers and countries are listed for CAMCEVI PROLONGED-RELEASE SUSPENSION FOR INJECTION 42 MG PER SYRINGE?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- Fareva Pau
- Sterigenics Belgium (Fleurus) (Contract Sterilization)
Manufacturing country/countries: FRANCE; BELGIUM
Where can I look up CAMCEVI PROLONGED-RELEASE SUSPENSION FOR INJECTION 42 MG PER SYRINGE in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN17580P or the exact product name CAMCEVI PROLONGED-RELEASE SUSPENSION FOR INJECTION 42 MG PER SYRINGE. The general register link does not preselect this product.
What are the source dates for this CAMCEVI PROLONGED-RELEASE SUSPENSION FOR INJECTION 42 MG PER SYRINGE record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this CAMCEVI PROLONGED-RELEASE SUSPENSION FOR INJECTION 42 MG PER SYRINGE record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN17580P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)